Decline in Prenatal Buprenorphine/Naloxone Fills during the COVID-19 Pandemic in the United States.

O'Donoghue, Ashley L; Reichheld, Alyse; Anderson, Timothy S; Zera, Chloe A; Dechen, Tenzin; Stevens, Jennifer P

O'Donoghue, Ashley L; Reichheld, Alyse; Anderson, Timothy S; Zera, Chloe A; Dechen, Tenzin; Stevens, Jennifer P.

Affiliation

O'Donoghue AL; From the Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA (ALO, AR, TSA, TD, JPS); Harvard Medical School, Boston, MA (ALO, TSA, CAZ, JPS); Tufts University School of Medicine, Boston, MA (AR); Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, MA (TSA); Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA (CAZ); and Division for Pulmonary, Critical Care, and

J Addict Med ; 17(6): e399-e402, 2023.

Article de En | MEDLINE | ID: mdl-37934549

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 Limites: Female / Humans / Pregnancy Pays/Région comme sujet: America do norte Langue: En Journal: J Addict Med Année: 2023 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google